Glass House Brands (GLAS) Beginning Cash Balance (2020 - 2023)
Glass House Brands' (GLAS) quarterly Beginning Cash Balance came in at $16.4 million in Q2 2023, down 34.09% year-on-year from $24.8 million in Q2 2022, and up 15.72% on a QoQ basis from $14.1 million in Q1 2023.
Glass House Brands (GLAS) Beginning Cash Balance (2020 - 2023) Analysis & Trends
Glass House Brands (GLAS) has 4 years of Beginning Cash Balance data on file, last reported at $16.4 million in Q2 2023.
- On a quarterly basis, Beginning Cash Balance fell 34.09% year-over-year to $16.4 million in Q2 2023; TTM through Jun 2023 was $72.9 million, a 100.0% decrease from a year earlier, with the FY2022 full-year figure at $17.5 million, up 286.66% from the prior year.
- Beginning Cash Balance for Q2 2023 stood at $16.4 million, up from $14.1 million in the prior quarter.
- Over the last five years, Beginning Cash Balance for GLAS reached as high as $4535.3 billion in Q3 2021 and fell as low as $14.1 million in Q1 2023.
- Historically, Beginning Cash Balance has averaged $1462.8 billion across 4 years, with a median of $39.4 million in 2022.
- Across the five-year window, Beginning Cash Balance soared 72.32% in 2021 and slumped 100.0% in 2022, its largest moves.
- Year by year, Beginning Cash Balance stood at $2631.9 billion in 2020, then soared by 72.32% to $4535.3 billion in 2021, then slumped by 100.0% to $17.5 million in 2022, then decreased by 6.66% to $16.4 million in 2023.
- Per Business Quant data, the three most recent Beginning Cash Balance figures were $16.4 million in Q2 2023, $14.1 million in Q1 2023, and $17.5 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 16.37 Mn |
| Jun 30, 2023 | 16.37 Mn |
| Mar 31, 2023 | 14.14 Mn |
| Mar 31, 2023 | 14.14 Mn |
| Dec 31, 2022 | 17.54 Mn |
| Dec 31, 2022 | 17.54 Mn |
| Jun 30, 2022 | 24.83 Mn |
| Jun 30, 2022 | 24.83 Mn |
| Mar 31, 2022 | 54.07 Mn |
| Mar 31, 2022 | 54.07 Mn |
| Dec 31, 2021 | 4,535.25 Bn |
| Dec 31, 2021 | 4,535.25 Bn |
| Sep 30, 2021 | 4,535.25 Bn |
| Sep 30, 2021 | 4,535.25 Bn |
| Dec 31, 2020 | 2,631.89 Bn |
| Dec 31, 2020 | 2,631.89 Bn |